Most Recent
Home builder Metricon has been ordered to identify the specific drawings it alleges a Queensland builder copied, in proceedings alleging copyright infringement of two of its home designs.
A delegate has ordered the removal of American chef and restaurateur Wolfgang Puck’s ‘Spago’ trade mark, upholding a challenge by a Sydney-based Italian restaurant with the same name.
In the latest ruling on computer-implemented inventions, an IP Australia delegate has shot down fintech Kyro Card's bid to patent a payment system for offering rewards to shoppers, finding the invention was a business scheme implemented on a computer and not a manner of manufacture.
Business management software company Sage Global has lost its challenge to registration of 'LawSage' as a trade mark for an AI-powered legal research and analysis platform.
IMB Bank will argue that a fintech's claims that the mutual bank breached its copyright by reverse engineering its customer relations management software is statute-barred, a court has heard.
Japanese pharmaceutical company Astellas Pharma has signed a deal worth up to $2 billion with Melbourne-based start-up Audax Biosciences to secure future rights to develop and commercialise its new cancer treatment.
The ABC has raised concerns about the use of children’s character Bluey in One Nation’s political cartoons, telling Senate estimates it was seeking legal advice on the matter.
UNSW Sydney academics have proposed a new framework under which AI companies would be required to disclose the sources used to train their models, compensate creators and remove unauthorised AI-generated content.
The Full Federal Court has published its reasons for finding Hytera copied a substantial part of Motorola's source code for its digital mobile radios, saying the 15 months of labour the China-based company saved from the copying reinforced its conclusion.
Swiss pharmaceutical company Actelion has brought a fourth patent infringement case over plans to launch a generic version of its blood pressure drug in Australia -- against Lupin unit Generic Health -- after firing off cases against three other drug makers.